Purpose To identify programmed cell death (PCD) pathways involved in N-methyl-N-nitrosourea (MNU)-induced photoreceptor (PR) degeneration. Methods Adult C57BL/6 mice received a single MNU i.p. injection (60 mg/kg bodyweight), and were observed over a period of 7 days. Degeneration was visualized by H&E overview staining and electron microscopy. PR cell death was measured by quantifying TUNEL-positive cells in the outer nuclear layer (ONL). Activity measurements of key PCD enzymes (calpain, caspases) were used to identify the involved cell death pathways. Furthermore, the expression level of C/EBP homologous protein (CHOP) and glucose-regulated protein 78 (GRP78), key players in endoplasmic reticulum (ER) stress-induced apoptosis, was analyzed using quantitative real-time PCR.
proliferation to stabilize the damaged retina was found after MNU treatment [8] . Macrophage-dependent clearance is thereby fundamental to the maintenance of neural tissue in the process of apoptotic cell death [9] . However, only PRs undergo cell death without damaging further retinal tissue, including the retinal pigment epithelium (RPE) [10] . Different mechanisms have been described to induce PR apoptosis, including oxidative stress and the loss of retinal blood supply [11] . As retinitis pigmentosa (RP) is a human disease that is characterized by PR loss leading to blindness, MNU-treated animals might serve as a model to investigate disease-associated features [12] . This could be especially true for RP forms that are caused by genesplicing mutations, which also share the characteristic of existing all over the body but affecting only the photoreceptors [13] . Another advantage, in addition to the specificity of PRs as target cells, is that MNU can be easily applied to all mouse strains without facing the necessity to intercross animals. Recent publications have provided more insight into the pathways involved in MNU-induced degeneration in the retina (see review [14] ). Today, there is still a substantial amount of contradictory hypotheses concerning the trigger of MNUinduced cell death.
To investigate whether multiple cellular suicide mechanisms participate in the degeneration events in the MNU model, as described for other retinal degenerations [15] , we have quantified the activity of key caspases of apoptotic pathways in retinal samples from MNU-treated mice and corresponding controls. In addition to the activation of caspase-3, as suggested by Yoshizawa et al. [5] , we further investigated activation of caspases 9 and 12. As the activation of calpains has been shown to trigger apoptosis in several animal models of retinal degeneration [16, 17] , we have also assessed calpain-related cell death events after MNU treatment.
Endoplasmic reticulum (ER) stress has been implicated recently in a wide variety of human diseases, including PR degeneration [18] . Cellular stress conditions, such as perturbed calcium homeostasis and the accumulation of unfolded proteins, activate ER stress [19] . Several sensors of ER stress have been identified, including caspase-12. Because of the detected activation of an ER stress-specific caspase cascade, including caspases 3, 9, and 12, we have additionally assessed the expression of glucose-regulated protein (GRP78) and C/EBP-homologous protein (CHOP), known as ER stress-related factors in photoreceptor degeneration [20] .
The aim of this study was to gain more insight into the pathways of programmed cell death (PCD) involved in MNU-induced photoreceptor degeneration. Herein, we provide evidence that multiple PCD pathways are involved. Our results will facilitate further studies aiming to develop putative therapeutic approaches for retinal degenerative diseases, including combinatory treatment with multifaceted inhibitors.
Methods
MNU treatment C57BL/6 mice (6-8 weeks old) received a single i.p. injection of sterile 1 % MNU (Sigma-Aldrich, Buchs, Switzerland) in saline containing 0.05 % acetic acid added immediately prior to injection. The final concentration of 60 mg/kg bodyweight and the investigated time points (d1, d3, and d7) post-injection (PI) were chosen in regard to previous trials that showed functional and histological changes at that dose and those time points [10] . Control animals received a similar volume of saline (0.9 % NaCl). No clinical signs of discomfort or weight loss were observed. The animals were treated according to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research, following approval by the commission for animal experimentation of the Canton of Bern, Switzerland.
Histology Eyes were fixed with 4 % paraformaldehyde (PFA; MERCK, Darmstadt, Germany) in phosphate-buffered saline (PBS; Life Technologies, Zug, Switzerland) overnight, embedded in paraffin (Fisher Scientific, Rheinach, Switzerland), and 5-μm sections were cut with a microtome (Leica RM2245; Biosystems, Muttenz, Switzerland). Sagittally oriented central sections at the level of the optic nerve head (ONH) were stained with Mayer's hemalum and eosin (H&E; Roth, Karlsruhe, Germany) and evaluated with NISElements (Nikon, Egg, Switzerland).
Electron microscopy Selected eyes (control, MNU) were fixed in Karnovksy solution (1 % PFA, 3 % glutaraldehyde, 3 % sodium cacodylate-HCl; Science Services, Munich, Germany) for at least 24 h before the lens was removed, after which the eyes were fixed for an additional 24 h. The eyecups were washed with EM buffer (2.5 % glutaraldehyde and 0.1 M sodium cacodylate-HCl) and then postfixed in 4 % osmium tetroxide (Science Services). The tissue was dehydrated, washed with a resin/1,2-propylene oxide mixture (MERCK) and mounted in resin (ERL 4221, DER 736, NSA, and DMAE), mixed according to the manufacturer's instructions (Science Services). The resin blocks were trimmed and semithin sections (1 μm) were cut. Overview staining with 0.5 % toluidine blue (Sigma) was performed to assure sampling on the level of the ONH. Ultrathin sections (80 nm) were then cut, contrasted with 0.1 % lead citrate (Sigma-Aldrich) and then visualized on a CM 12 electron microscope (EM; Philips Applied Technologies, Eindhoven, The Netherlands).
TUNEL staining Eyes were fixed with 4 % PFA at 4°C overnight, embedded in paraffin, and 5-μm sections were cut. To assess cell death, terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick-end labeling (TUNEL) was performed using the In Situ Cell Death Detection Kit, TMR red (Roche Diagnostics, Rotkreuz, Switzerland) according to the manufacturer's instructions. Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI, NucBlue® Fixed Cell ReadyProbes® Reagent, Life Technologies) and slides were mounted with ProLong® Gold Antifade Mountant (Life Technologies). Staining was visualized with a scanning laser microscope (Zeiss LSM710; Carl Zeiss Microscopy, Jena, Germany). TUNEL positive cells were counted in visual fields (n=9 per animal) of 61.14 mm 2 in the area of the posterior pole close to the optic nerve head.
Activity assays Calpain as well as caspase-3, -9 and -12 activity assays (BioVision, Milpitas, CA, USA) were performed on retinal lysates according to the manufacturer's instructions. Briefly, retinas (n≥4) were dissected, pooled, and lysed in RIPA buffer (150 mM NaCl, 1.0 % IGEPAL®, 0.5 % sodium deoxycholate, 0.1 % SDS, 50 mM Tris, pH 8.0; SigmaAldrich) supplemented with a cocktail of inhibitors to prevent protein degradation (Complete Mini; Roche). Cell lysates were analyzed using the DC Protein Assay (Bio-Rad, Cressier, Switzerland), and aliquots of 50 μg were introduced per assay. The samples were incubated for 1 h with the specific substrate, which emits a yellow-green fluorescence upon cleavage in the presence of the corresponding caspase or calpain protease. The cleaved substrate was then fluorometrically measured at 505 nm (Infinite 200PRO; Tecan, Männedorf, Switzerland). Activity data from MNUtreated animals were plotted against control values obtained from NaCl-injected mice for each specific time point PI. Furthermore, three independent retinal lysate samples of MNU-treated mice were supplemented with 100 μM of the calpain inhibitor Z-LLY-FMK (BioVision) before incubation in the substrate for 1 h, in order to confirm a specific activity after MNU treatment.
In situ activity assay Calpain activity was measured using the cell-permeable fluorescent substrate tert-butoxycarbonyl-Lmethionineamide-7-amino-4-chloromethylcouarim (t-Boc-LeuMet, CMAC, Molecular Probes, Inc., Eugene, OR, USA) [16] . Briefly, unfixed retinal cryosections obtained from MNU-treated and control mice were incubated in calpain reaction buffer (CRB: 25 mM HEPES, 65 mM KCl, 2 mM MgCl 2 , 2 mM DTT, 1.5 mM CaCl 2 ; Sigma-Aldrich) at room temperature for 15 min. This was followed by incubation with 2 μM t-Boc-LeuMet dissolved in CRB at 37°C in the dark for 1 h. After washing in TBS, the slides were fixed in 4 % PFA and assessed for apoptotic cell death using the In Situ Cell Death Detection Kit, Fluorescein (Roche) as described above. After washing with Tris-buffered saline (TBS, Sigma-Aldrich), slides were mounted with VECTASHIELD Mounting Medium with DAPI (Vector Laboratories, Burlingame, CA, USA). Images were analyzed using a fluorescence microscope (Eclipse 80i, Nikon)
Quantitative RT-PCR Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hombrechtikon, Switzerland) according to the manufacturer's instructions. Three independent samples obtained from four pooled retinas were used for each condition. RNA quantity and quality were assessed with the Experion Automated Electrophoresis system (Bio-Rad). For cDNA synthesis and subsequent qRT-PCR, only RNA samples with an RNA quality indicator (RQI)>7.0 were used. cDNA was synthesized from 1 μg of total RNA, using the iScript cDNA Synthesis Kit (Bio-Rad) according to the manufacturer's instructions. cDNA was purified with the PCR Purification Kit (Qiagen). qRT-PCR was performed using an iQ5 real-time PCR Detection System (Bio-Rad). The 25-μl PCR reaction mix included 12.5 μl of 1× iQ SYBR Green Supermix (Bio-Rad), 1 μl of cDNA (125 ng), 1 μl of each forward and reverse primer (400 nM), and 9.5 μl of dH 2 O. The following primer pairs were used: [20] . The reactions were incubated in a 96-well optical plate for 3 min at 95°C, followed by 50 cycles of 20 s at 95°C, 20 s at 58°C, 30 s at 72°C, 1 min incubation at 95°C, and a final incubation of 1 min at 75°C. Relative mRNA expression was calculated using GenEx software (MultiD Analyses, Gothenburg, Sweden). Cycle thresholds were normalized against the reference gene Gapdh. Expression data are presented as means±SD calculated against the control samples. Expression in control samples was set to '1'.
Statistics For each time point and dosage, the mean±SD of at least three independent experimental measures were calculated. SigmaPlot statistical software (Version 12; Systat Software, Erkrath, Germany) or SPSS (IBM, Hampshire, UK) was used to assess the data. The Student's t-test or oneway ANOVA test with post-hoc all pairwise multiple comparison procedures (Tukey's or Holm-Sidak test) was applied and differences were considered statistically significant at P≤ 0.05.
Results
Photoreceptor cell death after MNU treatment MNU treatment caused a dramatic decrease of ONL thickness over time, whereas the RPE appeared undisturbed. The panel shows representative images of the different time points investigated (Fig. 1) . These specific effects could also be visualized on the ultrastructural level, and were evident starting from day 3 PI (Fig. 2) . The nuclei in the ONL displayed the hyperchromatic characteristics of apoptotic cell death (Fig. 2a) . However, some nuclei had also changed shape, and displayed residual bodies and an altered chromatin structure (Fig. 2b) , a characteristic of late apoptotic cells. At the same time point, the interface between photoreceptor cells and RPE appeared degenerated. The photoreceptor nuclei intermingled with the disturbed outer segments, and could be visualized adjacent to the RPE monolayer (Fig. 2c) . The complete disappearance of the photoreceptor outer segments (Fig. 2d) was observed at the latest time point after treatment. At the same time point, the RPE layer still appeared healthy and displayed structures comparable to the control sample (Fig. 2e) , indicating the direct and photoreceptor-specific effect of MNU. The treatment triggered PR cell death, as TUNEL positivity was only detectable within the ONL (Fig. 3b-d) . The number of apoptotic cells was 4.0± 1.8 % on day 1 PI, reached the maximum with 60.4±14.6 % on day 3 PI, and was still 49.5±14.5 % on day 7 PI (Fig. 3e) . No TUNEL-positive cells were found in the control samples (Fig. 3a) .
PCD pathways in photoreceptor degeneration
To identify which cell death mechanisms were triggered by MNU, we investigated key molecules of caspase-dependent as well as caspase-independent pathways. MNU treatment led to an upregulation of the activity of several apoptotic caspases (Fig. 4) . Whereas no increase in caspase-3 expression (17.8± 8.1 RFU) was detectable at day 1 PI compared to the levels in control animals (15.8±11.9 RFU), a significant increase was however detectable 3 days PI (72.6±32.0 RFU; P<0.001), as well as at day 7 (51.1±11.4; P=0.02). The caspase activity was increased 5.8-fold and 3.7-fold respectively over the control values (12.6±4.3, 14.0±9.0). Besides the executer caspase-3, additional caspases were simultaneously upregulated after administration of MNU. Caspase-9 was upregulated up to 4.6-fold at day 1 PI in comparison to the value in control treated retinas (115.2±44.7 vs 26.3±17.1 RFU; P<0.01), whereas caspase-12 displayed a moderate but significant (P=0.02) two-fold increase in expression at day 1 PI compared to the control values (6737.4±1608.2 vs 3285.8±1308.5 RFU). The activation of caspase-3 confirmed the involvement of conventional apoptosis. However, other cell death mechanisms have to be addressed as caspaseindependent pathways might be involved as well.
Since in PR degeneration conventional cell death can be accompanied by the presence of activated calpains [22] , we further assessed the activity of these calcium-dependent proteases directly in an in-situ activity assay. Retinas from MNUinjected mice displayed calpain-positive cells in the ONL on day 3 PI (Fig. 5a ). Furthermore, a few TUNEL-positive cells in the ONL showed calpain activity (Fig. 5b) , indicating that the MNU-induced PR cell death is at least partially caspaseindependent. No such cells were found in the same layer of the control samples (Fig. 5c) . The obtained data were confirmed by a significant upregulation of activated calpain in protein lysates of retinas from MNU-treated animals compared to the controls at day 1 PI (16,546±560 RFU vs 11,804±1,669 RFU; P=0.03), at day 3 PI (19,245±836 RFU vs 14,042±1, 664 RFU; P=0.014) and at day 7 PI (19,771±2,383 RFU vs 13,379±2,099 RFU; P=0.002; Fig. 5d ). However, the upregulation was only moderate with a maximum increase of 47 % at day 7 PI, and therewith smaller than the caspase-3 activation (see above). Incubation of the lysates with the calpain inhibitor Z-LLY-FMK prior to adding the calpain substrate led to a significant downregulation of calpain activity, by 54 % (d3: 18,579±1,833 RFU in MNU-treated samples vs 8,574±667 RFU in the samples with the inhibitor).
Involvement of ER stress
MNU might also trigger activation of the ER stress pathway, as previously proposed [10] . The increased caspase-9 and Fig. 1 Morphological changes in the retina after treatment with MNU (60 mg/kg) over time. Representative images of H&E-stained retina sections showed significant changes in the sensory retina after the treatment (b-d) compared to the control (a). The panels show a decrease in the thickness of the ONL after treatment over time (control: a, day 1: b, day 3: c, day 7: d), whereas the RPE monolayer appears still intact, even at the latest time point investigated. The scale bar represents 100 μm caspase-12 activity (see above) at day 1 supports this assumption, as ER stress has been shown to activate these caspases in retinal degeneration [23] . To gain further insight, we have quantified the gene expression of CHOP and GRP78, known to be upregulated under ER stress conditions. An increase in the mRNA level compared to control was found after MNU treatment (Fig. 6 ). CHOP mRNA expression was significantly upregulated at all time points PI compared to the control (fold upregulation on d1 PI: 4.7±0.6, on d3 PI: 5.6±0.3, on d7 PI: 5.6±0.4; P<0.001) and reached a plateau on d3 PI. GRP78 was also significantly upregulated at all time points PI compared to the control (fold upregulation on d1 PI: 2.847±0.387, on d3 PI: 3.516±0.698, on d7 PI: 4.745±1.154; P<0.001); the values increased over time with the highest expression on day 7 PI.
Discussion
Animal models of retinal diseases are an important tool for studying degenerative processes as well as for developing potential treatment strategies to interfere with the induced cell death. Pharmacological approaches, including MNU-induced degeneration, have the advantage of an arbitrary modulation of onset and severity. The effect of MNU on PR cells in mice has been investigated, and it is the common understanding that apoptosis is thereby induced in PRs [13] . This was also evident in our experimental setting, as the number of TUNEL-positive cells in the ONL increased significantly in response to MNU administration over time (Fig. 1) . On the cellular level, PR outer segments were completely missing, whereas the RPE monolayer and Bruch's membrane remained intact. Subcellular changes were visualized using EM, and thereby chromatin condensation and apoptotic bodies were found exclusively in the ONL (Fig. 2) . Cell shrinkage and pyknosis due to chromatin condensation are early signs of apoptosis [24] . Therefore, a photoreceptor-specific toxicity of MNU has been suggested [10, 12, 25] . However, in addition to falsepositive cells due to EM preparation procedures, these cells imaged by EM represent exclusively late apoptotic cells, making it impossible to clearly define the involved cell death pathway.
Therefore, we investigated the underlying PCD components of MNU-induced PR degeneration. Earlier publications Fig. 2 Apoptotic nuclei (a; white arrowhead) appeared in the outer nuclear layer next to non-apoptotic nuclei 3 days after treatment with 60 mg/kg MNU. Nuclei with disordered but not fully condensed chromatin and apoptotic bodies (b; arrows) were found under the same conditions. At the same time point, the interface between photoreceptor cells and RPE was disturbed. Thereby, photoreceptor nuclei (*) and outer segments (#) interchanged adjacent to the RPE monolayer (c). Subsequently, photoreceptor outer segments were completely missing, whereas the RPE monolayer remained intact (d; arrows show microvilli) at later time points. Panel e shows healthy mouse retina with an RPE cell layer, microvilli (arrows), photoreceptor outer segments (black arrowheads) and Bruch's membrane (*) for comparison by us and others have pointed towards caspase-3-dependent and/or caspase-3-independent mechanisms [10, 26, 27] . Herein, we measured the significant upregulation of a cascade of proteases involved in cell death execution. Thereby, the activity of caspase-3, and to a lesser degree of caspases-9 and -12, was found to be increased (Fig. 4) . However, the detected values were relatively small compared to the substantial amount of PR cell death observed by TUNEL staining (Fig. 3) , indicating the contribution of other nonconventional cell death pathways. The relatively low expression of caspase-3 might also explain the nondetectability of this caspase in immunohistochemistry-only approaches [10] . Nevertheless, MNU has been shown to increase caspase-3 mRNA expression in the retina of MNU-treated rats [28] . Consistently, a caspase-3 inhibitor decreased the loss of photoreceptors in Sprague-Dawley rats after MNU treatment [5] .
As several studies have supported the idea of the contribution of calpains (calcium-dependent proteases) in degenerative processes, we have also quantified the level of calpain activity after MNU treatment. Calpains, ubiquitously expressed and activated depending on the concentration of calcium present, have been detected in PR cell death in rd1 mice [16] as well as in P23H and S334ter rhodopsin mutant rats [17] . Thereby, increased calcium levels are released from the ER or the mitochondria in response to toxic insult. In our samples, a significant upregulation of calpain activity in the MNU samples and colocalization of TUNEL-and calpainpositive cells in the ONL was also found (Fig. 5) . Nevertheless, compared to the high amount of TUNELpositive cells, we detected only a low number of cells displaying calpain activity. However, calpain activity was also present in samples obtained from wild type retinas. This result can be explained by occasional apoptotic events in the ONL, since photoreceptors are capable of executing developmental apoptosis at least until P42, as shown by Arango-Gonzalez and colleagues [29] . Our results are consistent with previous studies showing that the oral administration or i.p. delivery of a calpain inhibitor reduced but did not fully rescue the MNUinduced loss of photoreceptors [26, 30] . However, we cannot exclude the involvement of additional cell death pathways (e.g., PARP).
Caspase-12 plays a central role in ER stress-mediated apoptosis [31] . Upon activation by ER stress it translocates from the ER to the cytosol, where it directly cleaves pro-caspase-9, which, in turn, activates the effector caspase, caspase-3 [32] . The upregulation of this specific caspase cascade in our samples indicates an involvement of ER-related stress in MNU-induced Fig. 4 Activity assays for key caspases in PCD. Graphs depict the time course of caspase-3, -9, and -12 activities with and without MNU treatment. Sequential upregulation of initiators and effectors of PCD is seen. Error bars indicate the SD from three independent experiments, and statistically significant differences are indicated with an asterisk (P≤ 0.01). Note the different scale on the y-axes PCD. Furthermore, we were also able to detect CHOP and GRP78 on the transcriptional level after MNU treatment. CHOP is known to be induced in response to ER stress [33] , and activates Bim, a Bcl-2 family member, which is required for ER-stress mediated apoptosis [34] . Whereas CHOP mRNA expression was highly upregulated from day 1 PI and stayed elevated until 7 days PI, GRP78 expression increased continuously over time (Fig. 6) . Dying photoreceptors and their secreted factors might trigger stress response in other retinal cells. In this regard, the measured results, especially at day 7 where only approx. 10 % PR remain, represent the stress response from the remaining photoreceptors and adjacent retinal cells. Elevated GRP78 mRNA levels are a sensitive indicator of ER stress, and have been observed in diseases linked to ER stress [35] and in retinal degeneration models arising from P23H rhodopsin expression [36] . During ER stress, there is also an accumulation of misfolded proteins within the ER due to either primary (genetic) or secondary (environmental) factors [37] . Although the analysis of the unfolded protein response was not in the scope of this manuscript, our findings may suggest that this closely related pathway also participates in MNUinduced PR cell death.
In conclusion, regular apoptosis is the prevalent cause of MNU-induced PR cell death. However, involvement of alternative PCD pathways including ER stress and calpain activation was also found ( Table 1 ), indicating that the sole use of caspase inhibitors will not be reflects the quantification of calpain activity with and without MNU treatment over time. Significant upregulation has been measured at all time points, whereas adding the calpain inhibitor Z-LLY-FMK led to a significant decrease in the level of activated calpain (day 3 PI). Error bars indicate the SD from three independent experiments, and statistically significant differences are indicated with an asterisk (P≤ 0.01) sufficient to prevent MNU-induced photoreceptor cell death. It seems to be a common feature that several cell death pathways add to the degenerative process, and all of them would need to be inhibited to restore visual function. Thereby, the need for multimodal treatments to gain positive effects might be even more reflective of the in-situ situation of human diseases. In this regard, the MNU model could serve as a helpful tool to investigate such treatment options targeting the survival of neuronal cells in the degenerated retina. Another issue is the fact that the inhibition of one cell death pathway might trigger the activation of one or several others, further aggravating the course of the disease. Additionally, the severity of the damage might influence the involved cell death mechanisms. The use of appropriate concentrations of MNU provides a means of actively manipulating the duration and extent of photoreceptor degeneration. That might be usable to monitor possible beneficial effects after neuroprotective treatment or cell-based regenerative approaches. Nevertheless, MNU is a highly toxic and labile substance, demanding careful handling. As the specific mechanism of MNU action in the neuroretina is only partially known, investigation of this mechanism should be intensified in order to use the entire potential of the model. Expression in control samples was set to '1'. CHOP and GRP78 expression was significantly increased (*** P≤0.001) in MNU samples compared to control samples at all time points PI. As a result, CHOP expression levels remained steadily elevated at time points d3 and d7, but were significantly increased (* P≤0.05 / ** P≤0.005) when compared to d1. On the other hand, GRP78 expression increased continuously over the investigated time, with significant higher levels on d7 PI compared to d1 PI (* P≤ 0.05) 
